Emily Chen
Skyre (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Hippo pathway signaling and YAP/TAZ, Natural Language Processing Techniques, COVID-19 Clinical Research Studies, Computational Drug Discovery Methods
Most-Cited Works
- → Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19(2021)288 cited
- → The METLIN small molecule dataset for machine learning-based retention time prediction(2019)228 cited
- → The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis(2018)220 cited
- → Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry(2020)201 cited
- → Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19(2020)159 cited
- → Drug repurposing screens identify chemical entities for the development of COVID-19 interventions(2021)127 cited
- → An Evaluation of the Human-Interpretability of Explanation(2019)121 cited
- → Human Evaluation of Models Built for Interpretability(2019)105 cited
- → How do Humans Understand Explanations from Machine Learning Systems? An Evaluation of the Human-Interpretability of Explanation(2018)97 cited
- → Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia(2021)90 cited